William Blair Investment Management LLC Buys 10,863 Shares of Merit Medical Systems, Inc. $MMSI

William Blair Investment Management LLC grew its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 874,859 shares of the medical instruments supplier’s stock after acquiring an additional 10,863 shares during the period. William Blair Investment Management LLC owned 1.48% of Merit Medical Systems worth $77,110,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of MMSI. Blue Trust Inc. grew its holdings in Merit Medical Systems by 11.0% during the fourth quarter. Blue Trust Inc. now owns 1,853 shares of the medical instruments supplier’s stock worth $163,000 after purchasing an additional 184 shares during the period. First Horizon Corp lifted its position in Merit Medical Systems by 19.7% during the fourth quarter. First Horizon Corp now owns 1,117 shares of the medical instruments supplier’s stock worth $98,000 after acquiring an additional 184 shares during the last quarter. CANADA LIFE ASSURANCE Co lifted its position in Merit Medical Systems by 0.4% during the third quarter. CANADA LIFE ASSURANCE Co now owns 50,667 shares of the medical instruments supplier’s stock worth $4,095,000 after acquiring an additional 189 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in Merit Medical Systems by 1.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 13,562 shares of the medical instruments supplier’s stock worth $1,195,000 after acquiring an additional 200 shares during the last quarter. Finally, Arizona State Retirement System lifted its position in Merit Medical Systems by 1.4% during the third quarter. Arizona State Retirement System now owns 17,477 shares of the medical instruments supplier’s stock worth $1,455,000 after acquiring an additional 246 shares during the last quarter. Institutional investors own 99.66% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on MMSI shares. Citigroup reiterated an “outperform” rating on shares of Merit Medical Systems in a research report on Monday, April 20th. Barrington Research dropped their price target on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research report on Monday, April 20th. Robert W. Baird set a $83.00 price target on shares of Merit Medical Systems in a research report on Friday, May 1st. Piper Sandler dropped their price target on shares of Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. Finally, BTIG Research started coverage on shares of Merit Medical Systems in a research report on Friday, February 6th. They issued a “buy” rating and a $107.00 price target for the company. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and an average target price of $92.80.

Insiders Place Their Bets

In related news, insider Brian G. Lloyd bought 2,000 shares of the firm’s stock in a transaction on Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, with a total value of $125,240.00. Following the completion of the purchase, the insider owned 2,000 shares in the company, valued at $125,240. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Lynne N. Ward sold 5,000 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $62.61, for a total transaction of $313,050.00. Following the sale, the director directly owned 7,809 shares in the company, valued at approximately $488,921.49. The trade was a 39.04% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

Merit Medical Systems Price Performance

Shares of MMSI opened at $64.17 on Monday. Merit Medical Systems, Inc. has a one year low of $59.74 and a one year high of $97.18. The company has a market cap of $3.83 billion, a P/E ratio of 27.78, a P/E/G ratio of 2.00 and a beta of 0.58. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46. The firm has a 50 day simple moving average of $66.86 and a two-hundred day simple moving average of $77.72.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, beating the consensus estimate of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The business had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. During the same period in the previous year, the business earned $0.86 earnings per share. The company’s revenue was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Research analysts forecast that Merit Medical Systems, Inc. will post 3.61 EPS for the current fiscal year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.